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Abstract A short synthesis of alkyl 2-(bromomethyl)aziridine-2-carboxylates and alkyl 3-
bromoazetidine-3-carboxylates was developed involving amination, bromination and base-induced 
cyclization of alkyl 2-(bromomethyl)acrylates. The aziridines are the kinetically favored 
cyclization products and could be transformed into 3-bromoazetidine-3-carboxylic acid derivatives 
via thermal isomerization. The new small-membered azaheterocyclic α- and β-amino acid 
derivatives contain a bromo-substituted carbon center as a useful moiety for functionalization. 
Transformation of these functionalized azaheterocycles via nucleophilic substitution with carbon, 
sulfur, oxygen and nitrogen nucleophiles and via elaboration of the amino and carboxyl group 
provided a broad range of new conformationally constrained aziridine-2- and azetidine-3-
carboxylic acid derivatives which are of interest from a biological point-of-view as well as for 
applications in the field of foldamers. 
 
Keywords Aziridine-2-carboxylic acids, Azetidine-3-carboxylic acids, β-Amino 
acids, α-Amino acids, Conformational constraint 
 
Introduction 
Aziridine-2-carboxylic acid derivatives are biologically important constrained 
amino acid derivatives and versatile building blocks in the preparation of 
proteinogenic and non-proteinogenic amino acids and biologically active 
nitrogen-containing compounds (Cardillo et al. 2003, 2006; Lee and Ha 2003; 
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Lucarini and Tomasini 2001; Ide et al. 2005; Vicik et al. 2006). The latter is 
nicely exemplified by the ring opening of (2R)-N-(acetyl)aziridine-2-carboxylates 
1 in the synthesis of lacosamide (2, Vimpat

; UCB), approved in 2008 for the 
adjunctive treatment of partial onset seizures in patients with epilepsy (Figure 1) 
(Morieux et al. 2008; Hughes 2009b).
 
The different isomers of 2-(4-amino-4-
carboxybutyl)aziridine-2-carboxylate 3 (AziDAP) are irreversible inhibitors and 
substrate mimics of diaminopimelate (DAP) epimerase, a key enzyme for the 
biosynthesis of lysine in plants (Pillai et al. 2006, 2009). In view of the analogy 
with constrained β2,2-amino acids such as β2-HAib 5, 314-helix- and sheet-
breaking in β-peptides (Seebach and Gardiner 2008; Cheng et al. 2001), and 1-
(aminomethyl)cyclopropanecarboxylic acid 6, which forms β-oligopeptides with a 
ribbon- or stair-like structure (Abele et al. 1999), the unknown 2-
(aminomethyl)aziridine-2-carboxylic acids 4 are of significant interest as potential 
foldameric building blocks. Alternatively, derivatives of azetidine-3-carboxylic 
acid disclose gametocidal activity (Zhang et al. 2004; Verbrugge and De Waal 
1989; Orr and Clifford 1984; Devlin 1981), have found application as β-proline 
analogues (Mazzini et al. 1997), and have been used for the preparation of a 
variety of pharmaceutically active compounds (Miller et al. 2003). More 
specifically, a 3-aminoazetidine-3-carboxylic acid derivative has been 
incorporated in CE-178,253 (7, Pfizer), a CB1 antagonist for the treatment of 
obesity (Brandt et al. 2009). Furthermore, 3-aminoazetidine-3-carboxylic acid 
derivatives 8 also represent interesting conformationally constrained 
functionalized C
α
-tetrasubstituted α-amino acids, which have not been studied in 
the foldameric field. Related C
α
-tetrasubstituted α-amino acids such as Aib (9) 
and 1-aminocyclobutane-1-carboxylic acid (10, Ac4c) are known to form short 
peptides with a conformational preference for β-turns and 310-helices (Toniolo et 
al. 2006; Maity and König 2008; Soloshonok and Sorochinsky 2010). 
In view of the importance of the aforementioned classes of amino acids, the 
development of pathways to new three- and four-membered azaheterocyclic α- 
and β-amino acid derivatives is a challenging research field in modern synthetic 
chemistry at the biological interface (Hughes 2009a; Kiss and Fülöp 2010; Fülöp 
et al. 2006; Kuhl et al. 2005; Miller and Nguyen 2005; Cativiela and Ordóñez 
2009; Komarov et al. 2004; Cowell et al. 2004; Gelmi and Pocar 2003; Park and 
Kurth 2002). 
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Fig. 1 Several aziridine-2- and azetidine-3-carboxylic acid derivatives and related compounds with 
biological or foldameric applications 
 
Following a preliminary communication (Mangelinckx et al. 2008), in the present 
paper, in-depth results are described on the synthesis and study of the reactivity of 
2-(bromomethyl)aziridine-2-carboxylic esters and 3-bromoazetidine-3-carboxylic 
esters, the structures of which incorporate the synthetically important 2-
(halomethyl)aziridine (Abbaspour Tehrani et al. 2002; De Smaele et al. 1998; De 
Kimpe et al. 1997; D’hooghe et al. 2006a; Mangelinckx et al. 2009; Vervisch et 
al. 2010), or 3-haloazetidine structural motif (Van Driessche et al. 2006; Van 
Brabandt et al. 2009). The bromo-substituted carbon atom can be advantageously 
used as a moiety for functionalization. Allylamines have proven to be suitable 
substrates for the synthesis of 2-(bromomethyl)aziridines and/or 3-
bromoazetidines via bromination of the C-C double bond to the corresponding 
,γ-dibromo amines followed by intramolecular ring closure (Abbaspour Tehrani 
et al. 2002; De Smaele et al. 1998; De Kimpe et al. 1997; Hayashi et al. 2004; 
Gensler 1948), or via electrophile-induced bromocyclization (Robin and Rousseau 
2000, 2002). This ring closure usually has high selectivity towards the formation 
of aziridines instead of azetidines. 
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Material and methods 
 
Reagents and solvents were purchased from commercial suppliers and used 
without further purification, unless indicated otherwise. Dichloromethane was 
distilled from calcium hydride before use. The purification of reaction mixtures 
was performed through flash chromatography using a glass column with silica gel 
(0.035-0.070 nm, pore diameter ca. 6 nm) or by preparative thin layer 
chromatography on silica gel (silica gel GF preparative layer with UV 254, 2 
mm). Solvent systems were evaluated via TLC analysis (silica gel 2 – 25 μm, 
thickness 0.25 mm, medium pore diameter 60 Å with UV 254). 
1
H NMR (300 
MHz), 
13
C NMR (75 MHz) spectra were recorded on a JEOL ECLIPSE FT 300 
NMR spectrometer at room temperature. The compounds were dissolved in 
deuterated solvents as indicated for each compound. Tetramethylsilane (TMS) 
was used as an internal standard. IR spectra were recorded on a Perkin–Elmer 
Spectrum BX FT-IR spectrometer in neat form with an ATR (Attenuated Total 
Reflectance) accessory. Alternatively, IR spectra were recorded on a Perkin–
Elmer Spectrum One spectrometer. For liquid samples the spectra were collected 
by preparing a thin film of compound between two sodium chloride plates. Mass 
spectra were recorded on an Agilent 1100 series mass spectrometer using either a 
direct inlet system (electron spray, 4000V) or LC-MS coupling (UV detector). 
 
Synthesis of alkyl 2-[(alkylamino)methyl]acrylates 12a-d 
 
As a representative example, the synthesis of methyl 2-[(tert-
pentylamino)methyl]acrylate (12d) is described here. To a solution of tert-
pentylamine (175 mg, 2 mmol) and triethylamine (210 mg, 2.08 mmol) in CH2Cl2 
(10 mL), a solution of methyl 2-(bromomethyl)acrylate (11b) (358 mg, 2 mmol) 
in CH2Cl2 (5 mL) was added dropwise while stirring at 0 °C. After the reaction 
was stirred for 30 min at 0 °C, water (20 mL) was added to the reaction mixture, 
which was extracted with CH2Cl2 (3 × 20 mL). Drying (MgSO4), filtration and 
evaporation of the solvent under reduced pressure afforded methyl 2-[(tert-
pentylamino)methyl]acrylate (12d) in 98% yield which was used without further 
purification. 
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Ethyl 2-[(tert-butylamino)methyl]acrylate (12a) 
 
Yellow oil, yield 97%, Rf = 0.50 (petroleum ether/EtOAc 7/3). The 
1
H NMR data 
were in good agreement with reported data (Habaue et al. 1997). 
1
H NMR (300 
MHz, CDCl3): δ 1.14 (9H, s, C(CH3)3), 1.31 (3H, t, J = 7.2 Hz, CH2CH3), 3.40 
(2H, s, NCH2), 4.22 (2H, q, J = 7.2 Hz, CH2CH3), 5.78 (1H, dt, J = 1.3 Hz, 1.5 
Hz, C=CH(H)), 6.23 (1H, s, C=CH(H)). Anal. Calcd for C10H19NO2 (%): C, 
64.83; H, 10.34; N, 7.56. Found (%): C, 64.58; H, 10.56; N, 7.41. 
 
Ethyl 2-[(tert-pentylamino)methyl]acrylate (12b) 
 
Colorless oil, yield 91%, Rf = 0.51 (petroleum ether/EtOAc 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 0.86 (3H, t, J = 7.4 Hz, CCH2CH3), 1.06 (6H, s, C(CH3)2), 1.31 
(3H, t, J = 7.2 Hz, OCH2CH3), 1.44 (2H, q, J = 7.4 Hz, CCH2CH3), 3.34 (2H, s, 
NCH2), 4.22 (2H, q, J = 7.2 Hz, OCH2CH3), 5.79 (1H, dt, J =1.4 Hz, 1.4 Hz, 
C=CH(H)), 6.23 (1H, d, J = 0.8 Hz, C=CH(H)). 
13
C NMR (75 MHz, CDCl3): δ 
8.2, 14.2, 26.6, 33.1, 43.2, 52.7, 60.6, 125.4, 140.0, 166.9. IR (NaCl, cm
-1
) υNH = 
3328, υC=O = 1717, υC=C = 1635. MS (ES, pos. mode): m/z (%): 200 (M+H
+
, 100). 
Anal. Calcd for C11H21NO2 (%): C, 66.29; H, 10.62; N, 7.03. Found (%): C, 
66.12; H, 10.37; N, 7.22. 
 
Methyl 2-[(tert-butylamino)methyl]acrylate (12c) 
 
Colorless oil, yield 94%, Rf = 0.48 (petroleum ether/EtOAc 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 1.14 (9H, s, C(CH3)3), 3.41 (2H, br s, NCH2), 3.77 (3H, s, 
COOCH3), 5.80 (1H, dt, J = 1.5 Hz, 1.7 Hz, C=CH(H)), 6.23 (1H, d, J = 1.1 Hz, 
C=CH(H)). 
13
C NMR (75 MHz, CDCl3): δ 29.1, 43.8, 50.6, 51.8, 125.5, 139.9, 
167.4. IR (NaCl, cm
-1
): υNH = 3327, υC=O = 1719, υC=C = 1635. MS (ES, pos. 
mode): m/z (%): 172 (M+H
+
, 100). Anal. Calcd for C9H17NO2 (%): C, 63.13; H, 
10.01; N, 8.18. Found (%): C, 63.35; H, 10.34; N, 7.96. 
 
Methyl 2-[(tert-pentylamino)methyl]acrylate (12d) 
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Yellow oil, yield 98%, Rf = 0.50 (petroleum ether/EtOAc 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 0.86 (3H, t, J = 7.4 Hz, CH2CH3), 1.07 (6H, s, C(CH3)2), 1.44 
(2H, q, J = 7.4 Hz, CH2CH3), 3.35 (2H, s, CH2NH), 3.77 (3H, s, OCH3), 5.81 (1H, 
dt, J = 1.7 Hz, 1.4 Hz, C=CH(H)), 6.23 (1H, d, J = 1.4 Hz, C=CH(H)). 
13
C NMR 
(75 MHz, CDCl3): δ 8.3, 26.7, 33.2, 43.2, 51.9, 52.8, 125.7, 139.9, 167.5. IR 
(neat, cm
-1
): υNH = 3336 (weak), υC=O = 1718, υC=C = 1634. MS (ES, pos. mode): 
m/z (%): 186 (M+H
+
, 100). Anal. Calcd for C10H19NO2 (%): C, 64.83; H, 10.34; 
N, 7.56. Found (%): C, 64.60; H, 10.41; N, 7.34. 
 
Bromination of alkyl 2-[(alkylamino)methyl]acrylates 12a-d 
 
As a representative example, the synthesis of methyl 2-[(tert-
pentylamino)methyl]-2,3-dibromopropanoate (13d) is described here. To a 
solution of methyl 2-[(tert-pentylamino)methyl]acrylate (12d) (330 mg, 1.78 
mmol) in CH2Cl2 (30 mL), a 48% aqueous solution of hydrobromic acid (332 mg, 
1.96 mmol) was added dropwise at 0 °C and the reaction mixture was stirred for 
30 min. Then, a solution of Br2 (285 mg, 1.78 mmol) in CH2Cl2 (15 mL) was 
added dropwise and the reaction mixture was left stirring upon warming to room 
temperature for 5 h. Subsequently, the resulting reaction mixture was neutralised 
by pouring into saturated NaHCO3 solution and extracted with EtOAc (3 × 20 
mL). Drying (MgSO4), filtration, evaporation of the solvent under reduced 
pressure and purification by flash chromatography on silica gel (petroleum 
ether/EtOAc 9/1) afforded dibromo ester 13d in 97% yield. 
 
Ethyl 2-[(tert-butylamino)methyl]-2,3-dibromopropanoate (13a) 
 
Colorless oil, yield 98%, Rf = 0.50 petroleum ether/EtOAc 9/1). 
1
H NMR (300 
MHz, CDCl3): δ 1.16 (9H, s, C(CH3)3), 1.34 (3H, t, J = 7.2 Hz, CH2CH3), 3.24 
(1H, d, J = 13.8 Hz, NCH(H)), 3.30 (1H, d, J = 13.8 Hz, NCH(H)), 4.08 (1H, d, J 
= 9.9 Hz, CH(H)Br), 4.23 (1H, d, J = 9.9 Hz, CH(H)Br), 4.22-4.39 (2H, m, 
CH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 13.9, 28.5, 34.6, 46.6, 54.0, 59.8, 63.0, 
168.0. IR (NaCl, cm
-1
): υNH = 3327, υC=O = 1739. MS (ES, pos. mode): m/z (%): 
344/346/348 (M+H
+
, 100). Anal. Calcd for C10H19Br2NO2 (%): C, 34.81; H, 5.55; 
N, 4.06. Found (%): C, 34.48; H, 5.32; N, 3.84. 
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Ethyl 2-[(tert-pentylamino)methyl]-2,3-dibromopropanoate (13b) 
 
Colorless oil, yield 97%, Rf = 0.71 (CH2Cl2). 
1
H NMR (300 MHz, CDCl3): δ 0.86 
(3H, t, J = 7.4 Hz, CCH2CH3), 1.04 (3H, s, CCH3(CH3)), 1.05 (3H, s, 
CCH3(CH3)), 1.34 (3H, t, J = 7.2 Hz, OCH2CH3), 1.40 (2H, q, J = 7.3 Hz, 
CCH2CH3), 3.15 (1H, d, J = 13.8 Hz, NCH(H)), 3.20 (1H, d, J = 13.8 Hz, 
NCH(H)), 4.06 (1H, d, J = 9.6 Hz, CBrH(H)), 4.22 (1H, d, J = 9.6 Hz, CBrH(H)), 
4.28 (1H, dq, J = 7.2 Hz, 10.7 Hz, OCH(H)), 4.32 (1H, dq, J = 7.2 Hz, 10.7 Hz, 
OCH(H)). 
13
C NMR (75 MHz, CDCl3): δ 8.2, 13.9, 26.8, 27.0, 33.6, 34.4, 45.9, 
52.4, 62.4, 62.7, 168.2. IR (NaCl, cm
-1
): υNH = 3327 (weak), υC=O = 1742. MS 
(ES, pos. mode): m/z (%): 358/360/362 (M+H
+
, 100). Anal. Calcd for 
C11H21Br2NO2 (%): C, 36.79; H, 5.89; N, 3.90. Found (%): C, 36.62; H, 6.12; N, 
3.81. 
 
Methyl 2-[(tert-butylamino)methyl]-2,3-dibromopropanoate (13c) 
 
Yellow oil, yield 90%, Rf = 0.53 (petroleum ether/EtOAc 9/1). Spectroscopically 
characterized as the hydrobromide before neutralization. 
1
H NMR (300 MHz, 
DMSO-d6): δ 1.37 (9H, s, C(CH3)3), 3.69 (2H, br s, NCH2), 3.84 (3H, s, OCH3), 
4.27 (1H, d, J = 11.0 Hz, BrCH(H)), 4.41 (1H, d, J = 10.7 Hz, BrCH(H)), 8.58 
and 8.65 (2H, 2×br s, NH·HBr). 
13
C NMR (75 MHz, DMSO-d6): δ 24.8, 35.3, 
46.2, 54.1, 55.6, 59.0, 166.7. IR (NaCl, cm
-1
): υNH = 3445, υC=O = 1740. MS (ES, 
pos. mode): m/z (%): 330/332/334 (M-HBr+H
+
, 100). Anal. Calcd for 
C9H17Br2NO2 (%): C, 32.65; H, 5.18; N, 4.23. Found (%): C, 32.29; H, 5.36; N, 
4.07. 
 
Methyl 2-[(tert-pentylamino)methyl]-2,3-dibromopropanoate (13d) 
 
Yellow oil, yield 97%, Rf = 0.50 (petroleum ether/EtOAc 9/1). 
1
H NMR (300 
MHz, CDCl3): δ 0.86 (3H, t, J = 7.4 Hz, CH2CH3), 1.04 (3H, s, CH3CCH3), 1.05 
(3H, s, CH3CCH3), 1.40 (2H, q, J = 7.4 Hz, CH2CH3), 1.56 (1H, br s, NH), 3.16 
(1H, d, J = 13.5 Hz, NHCH(H)), 3.20 (1H, d, J = 13.8 Hz, NHCH(H)), 3.84 (3H, 
s, OCH3), 4.06 (1H, d, J = 9.6 Hz, CH(H)Br), 4.22 (1H, d, J = 9.6 Hz, CH(H)Br). 
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13
C NMR (75 MHz, CDCl3): δ 8.4, 26.9, 27.0, 33.7, 34.5, 46.1, 52.5, 53.4, 62.6, 
168.9. MS (ES, pos. mode): m/z (%): 344/346/348 (M+H
+
, 100). Anal. Calcd for 
C10H19Br2NO2 (%): C, 34.81; H, 5.55; N, 4.06. Found (%): C, 34.69; H, 5.75; N, 
3.80. 
 
Synthesis of alkyl 2-(bromomethyl)aziridine-2-carboxylates 14a-d and alkyl 3-
bromoazetidine-3-carboxylates 15a-d 
 
As a representative example, the synthesis of methyl 1-tert-pentyl-2-
(bromomethyl)aziridine-2-carboxylate (14d) and methyl 1-tert-pentyl-3-
bromoazetidine-3-carboxylate (15d) is described here. To a solution of methyl 2-
[(tert-pentylamino)methyl]-2,3-dibromopropanoate (13d) (618 mg, 1.79 mmol) in 
CH3CN (30 mL) was added powdered K2CO3 (371 mg, 2.69 mmol) and the 
reaction mixture was stirred at 60 °C for 18 h. Then the solvent was removed 
under reduced pressure and Et2O (30 mL) was added. The resulting solution was 
filtered and the filter cake was washed with small portions of Et2O. Evaporation 
of the solvent under reduced pressure and purification by preparative TLC on 
silica gel (petroleum ether/Et2O 7/3) afforded aziridine 14d in 54% yield and 
azetidine 15d in 26% yield. 
 
Ethyl 1-tert-butyl-2-(bromomethyl)aziridine-2-carboxylate (14a) 
 
Light yellow oil, yield 50%, Rf = 0.48 (petroleum ether/Et2O 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 1.08 (9H, s, (CH3)3), 1.33 (3H, t, J = 7.2 Hz, CH2CH3), 1.83 (1H, 
d, J = 1.1 Hz, NCH(H)), 2.55 (1H, dd, J = 1.1 Hz, 1.1 Hz, NCH(H)), 3.03 (1H, d, 
J = 9.9 Hz, BrCH(H)), 4.05 (1H, dd, J = 9.9 Hz, 1.1 Hz, BrCH(H)), 4.21 (1H, dq, 
J = 10.7 Hz, 7.2 Hz, CH(H)CH3), 4.26 (1H, dq, J = 11.0 Hz, 7.15 Hz, 
CH(H)CH3). 
13
C NMR (75 MHz, CDCl3): δ 14.1, 28.2, 33.6, 37.0, 45.2, 55.1, 
61.8, 169.6. IR (neat, cm
-1
): υC=O = 1732. MS (ES, pos. mode): m/z (%): 264/266 
(M+H
+
, 100). Anal. Calcd for C10H18BrNO2 (%): C, 45.47; H, 6.87; N, 5.30. 
Found (%): C, 45.41; H, 6.98; N, 5.19. 
 
Ethyl 1-tert-butyl-3-bromoazetidine-3-carboxylate (15a) 
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Yellow oil, yield 33%, Rf = 0.20 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.96 (9H, s, C(CH3)3), 1.32 (3H, t, J = 7.2 Hz, CH2CH3), 3.62 (2H, d, J 
= 9.9 Hz, CH(H)NCH(H)), 3.93 (2H, d, J = 9.9 Hz, CH(H)NCH(H)), 4.28 (2H, q, 
J = 7.2 Hz, CH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 13.9, 24.1, 45.2, 52.4, 59.6, 
62.4, 170.4. IR (neat, cm
-1
): υC=O = 1739. MS (ES, pos. mode): m/z (%): 264/266 
(M+H
+
, 100). Anal. Calcd for C10H18BrNO2 (%): C, 45.47; H, 6.87; N, 5.30. 
Found (%): C, 45.38; H, 7.06; N, 5.41. 
 
Ethyl 1-tert-pentyl-2-(bromomethyl)aziridine-2-carboxylate (14b) 
 
Light yellow oil, yield 54%, Rf = 0.48 (petroleum ether/Et2O 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 0.90 (3H, t, J = 7.4 Hz, CCH2CH3), 0.95 (3H, s, CCH3(CH3)), 
0.97 (3H, s, CCH3(CH3)), 1.33 (3H, t, J = 7.2 Hz, OCH2CH3), 1.45 (1H, qd, J = 
7.3 Hz, 13.5 Hz, CCH(H)CH3), 1.49 (1H, qd, J = 7.6 Hz, 13.6 Hz, CH(H)CH3), 
1.84 (1H, d, J = 1.1 Hz, NCH(H)), 2.59 (1H, dd, J = 1.2 Hz, 1.2 Hz, NCH(H)), 
3.03 (1H, d, J = 9.9 Hz, BrCH(H)), 4.07 (1H, dd, J = 1.2 Hz, 10.0 Hz, BrCH(H)), 
4.21 (1H, dq, J = 7.0 Hz, 10.7 Hz, OCH(H)), 4.26 (1H, dq, J = 7.1 Hz, 10.6 Hz, 
OCH(H)). 
13
C NMR (75 MHz, CDCl3): δ 8.7, 14.0, 24.0, 24.4, 33.7, 36.4, 37.0, 
44.4, 57.4, 61.6, 169.7. IR (neat, cm
-1
): υC=O = 1736. MS (ES, pos. mode): m/z 
(%): 278/280 (M+H
+
, 100). Anal. Calcd for C11H20BrNO2 (%): C, 47.49; H, 7.25; 
N, 5.04. Found (%): C, 47.24; H, 7.41; N, 4.82. 
 
Ethyl 1-tert-pentyl-3-bromoazetidine-3-carboxylate (15b) 
 
Yellow oil, yield 24%, Rf = 0.48 (petroleum ether/EtOAc 9/1). 
1
H NMR (300 
MHz, CDCl3): δ 0.83 (3H, t, J = 7.6 Hz, CCH2CH3), 0.88 (6H, s, C(CH3)2), 1.24 
(2H, q, J = 7.4 Hz, CCH2CH3), 1.32 (3H, t, J = 7.0 Hz, OCH2CH3), 3.60 (2H, d, J 
= 9.6 Hz, CH(H)NCH(H)), 3.90 (2H, d, J = 9.6 Hz, CH(H)NCH(H)), 4.28 (2H, q, 
J = 7.1 Hz, OCH2). 
13
C NMR (75 MHz, CDCl3): δ 8.5, 13.9, 20.1, 31.5, 45.5, 
54.7, 59.3, 62.2, 170.4. IR (neat, cm
-1
): υC=O = 1739. MS (ES, pos. mode): m/z 
(%): 278/280 (M+H
+
, 90). Anal. Calcd for C11H20BrNO2 (%): C, 47.49; H, 7.25; 
N, 5.04. Found (%): C, 47.41; H, 7.36; N, 4.84. 
 
Methyl 1-tert-butyl-2-(bromomethyl)aziridine-2-carboxylate (14c) 
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Light yellow oil, yield 44%, Rf = 0.45 (petroleum ether/Et2O 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 1.07 (9H, s, (CH3)3), 1.84 (1H, d, J = 1.1 Hz, NCH(H)), 2.55 
(1H, dd, J = 1.1 Hz, 1.0 Hz, NCH(H)), 3.06 (1H, d, J = 9.9 Hz, BrCH(H)), 3.78 
(3H, s, OCH3), 4.05 (1H, dd, J = 10.2 Hz, 1.1 Hz, BrCH(H)). 
13
C NMR (75 MHz, 
CDCl3): δ 28.2, 33.6, 36.7, 45.0, 52.7, 55.1, 170.2. IR (neat, cm
-1
): υC=O = 1732. 
MS (ES, pos. mode): m/z (%): 250/252 (M+H
+
, 100). Anal. Calcd for 
C9H16BrNO2 (%): C, 43.22; H, 6.45; N, 5.60. Found (%): C, 43.06; H, 6.69; N, 
5.34. 
 
Methyl 1-tert-butyl-3-bromoazetidine-3-carboxylate (15c) 
 
Yellow oil, yield 25%, Rf = 0.16 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.96 (9H, s, C(CH3)3), 3.60-3.64 (2H, m, CH(H)NCH(H)), 3.83 (3H, s, 
OCH3), 3.91-3.95 (2H, m, CH(H)NCH(H)). 
13
C NMR (75 MHz, CDCl3): δ 24.1, 
44.9, 52.4, 53.5, 59.7, 170.9. IR (neat, cm
-1
): υC=O = 1736. MS (ES, pos. mode): 
m/z (%): 250/252 (M+H
+
, 100). Anal. Calcd for C9H16BrNO2 (%): C, 43.22; H, 
6.45; N, 5.60. Found (%): C, 42.83; H, 6.61; N, 5.41. 
 
Methyl 1-tert-pentyl-2-(bromomethyl)aziridine-2-carboxylate (14d) 
 
Light yellow oil, yield 54%, Rf = 0.48 (petroleum ether/Et2O 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 0.90 (3H, t, J = 7.6 Hz, CH2CH3), 0.94 (3H, s, CH3CCH3), 0.96 
(3H, s, CH3CCH3), 1.36-1.58 (2H, m, CH2CH3), 1.85 (1H, s, NCH(H)), 2.59 (1H, 
s, NCH(H)), 3.05 (1H, d, J = 9.9 Hz, BrCH(H)), 3.77 (3H, s, OCH3), 4.07 (1H, d, 
J = 10.2 Hz, BrCH(H)). 
13
C NMR (75 MHz, CDCl3): δ 8.8, 24.1, 24.4, 33.9, 36.5, 
36.9, 44.3, 52.7, 57.4, 170.4. IR (neat, cm
-1
): υC=O = 1732. MS (ES, pos. mode): 
m/z (%): 264/266 (M+H
+
, 100). Anal. Calcd for C10H18BrNO2 (%): C, 45.47; H, 
6.87; N, 5.30. Found (%): C, 45.38; H, 6.98; N, 5.02. 
 
Methyl 1-tert-pentyl-3-bromoazetidine-3-carboxylate (15d) 
 
Yellow oil, yield 26%, Rf = 0.31 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.83 (3H, t, J = 7.4 Hz, CH2CH3), 0.88 (6H, s, C(CH3)2), 1.24 (2H, q, J 
11 
= 7.4 Hz, CH2CH3), 3.59-3.62 (2H, m, CH(H)NCH(H)), 3.83 (3H, s, OCH3), 
3.89-3.92 (2H, m, CH(H)NCH(H)). 
13
C NMR (75 MHz, CDCl3): δ 8.6, 20.1, 31.6, 
45.3, 53.4, 54.8, 59.5, 171.0. IR (neat, cm
-1
): υC=O = 1742. MS (ES, pos. mode): 
m/z (%): 264/266 (M+H
+
, 100). Anal. Calcd for C10H18BrNO2 (%): C, 45.47; H, 
6.87; N, 5.30. Found (%): C, 45.12; H, 7.08; N, 5.42. 
 
Isomerisation of alkyl 2-(bromomethyl)aziridines 14a-d to alkyl 3-
bromoazetidines 15a-d 
 
As a representative example, the synthesis of methyl 1-tert-pentyl-3-
bromoazetidine-3-carboxylate (15d) is described here. Methyl 1-tert-pentyl-2-
(bromomethyl)aziridine-2-carboxylate (14d) (100 mg, 0.38 mmol) was dissolved 
in DMSO (2 mL) and heated at 70 °C for 5 h. After cooling, the reaction mixture 
was poured into water (2 mL) and extracted with EtOAc (3 × 15 mL). The 
combined organic extracts were washed with brine (2 × 15 mL) and water (15 
mL). Drying (MgSO4), filtration, evaporation of the solvent under reduced 
pressure and purification by preparative TLC on silica gel (hexane/EtOAc 9/1) 
afforded azetidine 15d in 50% yield. 
 
Synthesis of alkyl 2-(cyanomethyl)aziridine-2-carboxylates 16a-c 
 
As a representative example, the synthesis of methyl 1-tert-butyl-2-
(cyanomethyl)aziridine-2-carboxylate (16c) is described here. A solution of 
methyl 1-tert-butyl-2-(bromomethyl)aziridine-2-carboxylate (14c) (118 mg, 0.47 
mmol) and potassium cyanide (31 mg, 0.47 mmol) in DMSO (2 mL) was heated 
at 60 °C for 4 h. After cooling, the reaction mixture was poured into water (15 
mL) and extracted with Et2O (3 × 15 mL). The combined organic extracts were 
washed with brine (2 × 15 mL) and water (15 mL). Drying (MgSO4), filtration, 
evaporation of the solvent under reduced pressure and purification by preparative 
TLC on silica gel (petroleum ether/EtOAc 8/2) afforded 2-(cyanomethyl)aziridine 
16c in 57% yield. 
 
Ethyl 1-tert-butyl-2-(cyanomethyl)aziridine-2-carboxylate (16a) 
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Pink oil, yield 47%, Rf = 0.26 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 1.12 (9H, s, C(CH3)3), 1.34 (3H, t, J = 7.2 Hz, CH2CH3), 1.95 (1H, d, J 
= 1.4 Hz, NCH(H)), 2.60 (1H, d, J = 1.1 Hz, NCH(H)), 2.65 (1H, d, J = 17.1 Hz, 
CH(H)CN), 2.81 (1H, d, J = 16.8 Hz, CH(H)CN), 4.21 (1H, dq, J = 11.0 Hz, 7.2 
Hz, CH(H)CH3), 4.87 (1H, dq, J = 10.9 Hz, 7.2 Hz, CH(H)CH3). 
13
C NMR (75 
MHz, CDCl3): δ 14.0, 25.4, 28.4, 33.6, 39.9, 54.9, 62.2, 117.3, 169.7. IR (neat, 
cm
-1
): υCN = 2253 (weak), υC=O = 1733. MS (ES, pos. mode): m/z (%): 211 
(M+H
+
, 100). Anal. Calcd for C11H18N2O2 (%): C, 62.83; H, 8.63; N, 13.32. 
Found (%): C, 62.95; H, 8.78; N, 13.17. 
 
Ethyl 1-tert-pentyl-2-(cyanomethyl)aziridine-2-carboxylate (16b) 
 
Pink oil, yield 54%, Rf = 0.29 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.92 (3H, t, J = 7.4 Hz, CCH2CH3)), 1.00 (3H, s, CCH3), 1.01 (3H, s, 
CCH3), 1.33 (3H, t, J = 7.2 Hz, OCH2CH3), 1.39-1.56 (2H, m, CCH2CH3)), 1.97 
(1H, d, J = 1.7 Hz, NCH(H)), 2.63 (1H, d, J = 1.4 Hz, NCH(H)), 2.66 (1H, d, J = 
16.8 Hz, CH(H)CN), 2.84 (1H, d, J = 16.8 Hz, CH(H)CN), 4.21 (1H, dq, J = 10.7 
Hz, 7.2 Hz, OCH(H)CH3), 4.26 (1H, dq, J = 10.7 Hz, 7.2 Hz, OCH(H)CH3). 
13
C 
NMR (75 MHz, CDCl3): δ 8.8, 14.0, 23.9, 24.6, 25.3, 33.8, 37.0, 39.2, 57.2, 62.2, 
117.3, 169.9. IR (neat, cm
-1
): υCN = 2253 (weak), υC=O = 1734. MS (ES, pos. 
mode): m/z (%): 225 (M+H
+
, 100). Anal. Calcd for C12H20N2O2 (%): C, 64.26; H, 
8.99; N, 12.49. Found (%): C, 64.01; H, 8.84; N, 12.61. 
 
Methyl 1-tert-butyl-2-(cyanomethyl)aziridine-2-carboxylate (16c) 
 
Yellow oil, yield 57%, Rf = 0.24 (petroleum ether/EtOAc 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 1.11 (9H, s, (CH3)3), 1.96 (1H, d, J = 1.4 Hz, NCH(H)), 2.60 
(1H, d, J = 1.4 Hz, NCH(H)), 2.67 (1H, d, J = 16.8 Hz, CH(H)CN), 2.81 (1H, d, J 
= 17.1 Hz, CH(H)CN), 3.79 (3H, s, OCH3).
 13
C NMR (75 MHz, CDCl3): δ 25.2, 
28.4, 33.7, 39.7, 53.0, 54.8, 117.2, 170.2. IR (neat, cm
-1
): υCN = 2253 (weak), υC=O 
= 1728. MS (ES, pos. mode): m/z (%): 197 (M+H
+
, 100). Anal. Calcd for 
C10H16N2O2 (%): C, 61.20; H, 8.22; N, 14.27. Found (%): C, 61.14; H, 8.43; N, 
14.25. 
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Synthesis of alkyl 2-(thiocyanomethyl)aziridine-2-carboxylates 17a-b 
 
As a representative example, the synthesis of ethyl 1-tert-butyl-2-
(thiocyanomethyl)aziridine-2-carboxylate (17a) is described here. A solution of 
ethyl 1-tert-butyl-2-(bromomethyl)aziridine-2-carboxylate (14a) (132 mg, 0.5 
mmol) and potassium thiocyanate (97 mg, 1 mmol) in DMF (2 mL) was heated at 
70 °C for 2 h. After cooling, the reaction mixture was poured into water (15 mL) 
and extracted with EtOAc (3 × 15 mL). The combined organic extracts were 
washed with brine (2 × 15 mL) and water (15 mL). Drying (MgSO4), filtration, 
evaporation of the solvent under reduced pressure and purification by preparative 
TLC on silica gel (petroleum ether/Et2O 7/3) afforded 2-
(thiocyanomethyl)aziridine 17a in 48% yield. 
 
Ethyl 1-tert-butyl-2-(thiocyanomethyl)aziridine-2-carboxylate (17a) 
 
Yellow oil, yield 48%, Rf = 0.31 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 1.10 (9H, s, (CH3)3), 1.33 (3H, t, J = 7.2 Hz, CH2CH3), 2.05 (1H, d, J = 
1.2 Hz, NCH(H)), 2.64 (1H, s, NCH(H)), 3.28 (1H, d, J = 12.9 Hz, CH(H)SCN), 
3.39 (1H, d, J = 12.9 Hz, CH(H)SCN), 4.20 (1H, dq, J = 11.0 Hz, 7.2 Hz, 
CH(H)CH3), 4.28 (1H, dq, J = 10.7 Hz, 7.2 Hz, CH(H)CH3). 
13
C NMR (75 MHz, 
CDCl3): δ 14.0, 28.3, 33.4, 40.2, 42.7, 54.9, 62.2, 113.1, 169.7. IR (neat, cm
-1
): 
υSCN = 2154, υC=O = 1735. MS (ES, pos. mode): m/z (%): 243 (M+H
+
, 100). Anal. 
Calcd for C11H18N2O2S (%): C, 54.52; H, 7.49; N, 11.56. Found (%): C, 54.69; H, 
7.61; N, 11.37. 
 
Ethyl 1-tert-pentyl-2-(thiocyanomethyl)aziridine-2-carboxylate (17b) 
 
Yellow oil, yield 44%, Rf = 0.30 (petroleum ether/EtOAc 9/1). 
1
H NMR (300 
MHz, CDCl3): δ 0.91 (3H, t, J = 7.7 Hz, CCH2CH3), 0.98 (3H, s, CCH3), 1.01 
(3H, s, CCH3), 1.33 (3H, t, J = 7.2 Hz, OCH2CH3), 1.37-1.58 (2H, m, CCH2CH3), 
2.07 (1H, s, NCH(H)), 2.66 (1H, s, NCH(H)), 3.32 (1H, d, J = 12.9 Hz, 
CH(H)SCN), 3.43 (1H, d, J = 13.2 Hz, CH(H)SCN), 4.19 (1H, dq, J = 10.7 Hz, 
7.2 Hz, OCH(H)CH3), 4.27 (1H, dq, J = 11.0 Hz, 7.2 Hz, OCH(H)CH3). 
13
C NMR 
(75 MHz, CDCl3): δ 8.8, 14.0, 23.9, 24.7, 33.4, 36.8, 40.3, 42.0, 57.3, 62.2, 113.1, 
14 
169.9. IR (neat, cm
-1
): υSCN = 2155, υC=O = 1735. MS (ES, pos. mode): m/z (%): 
257 (M+H
+
, 100). Anal. Calcd for C12H20N2O2S (%): C, 56.22; H, 7.86; N, 10.93. 
Found (%): C, 55.98; H, 8.02; N, 10.68.  
 
Synthesis of alkyl 2-(azidomethyl)aziridine-2-carboxylates 18a-d 
 
As a representative example, the synthesis of methyl 1-tert-butyl-2-
(azidomethyl)aziridine-2-carboxylate (18c) is described here. Methyl 1-tert-
butyl-2-(bromomethyl)aziridine-2-carboxylate (14c) (250 mg, 1 mmol) and 
sodium azide (130 mg, 2 mmol) were heated in DMSO (5 mL) at 60 °C for 3 h. 
After cooling, the reaction mixture was poured into water (15 mL) and extracted 
with Et2O (3 × 25 mL). The combined organic extracts were washed with brine 
(2 × 15 mL) and water (15 mL). Drying with MgSO4, filtration of the drying 
agent, evaporation of the solvent under reduced pressure and purification by 
flash chromatography on silica gel (Hexane/Et2O 9/1 - 7/3) afforded 2-
(azidomethyl)aziridine 18c in 91% yield. 
 
Ethyl 1-tert-butyl-2-(azidomethyl)aziridine-2-carboxylate (18a) 
 
Yellow oil, yield 58%, Rf = 0.47 (petroleum ether/EtOAc 8/2). 
1
H NMR (300 
MHz, CDCl3): δ 1.09 (9H, s, C(CH3)3), 1.33 (3H, t, J = 7.2 Hz, CH2CH3), 1.88 
(1H, d, J = 1.7 Hz, NCH(H)), 2.47-2.48 (1H, m, NCH(H)), 3.26 (1H, d, J = 12.7 
Hz, CH(H)N3), 3.68 (1H, d, J = 12.7 Hz, CH(H)N3), 4.19 (1H, dq, J = 10.7 Hz, 
7.2 Hz, OCH(H)CH3), 4.26 (1H, dq, J = 10.7 Hz, 7.2 Hz, OCH(H)CH3). 
13
C NMR 
(75 MHz, CDCl3): δ 14.0, 28.3, 32.0, 43.1, 54.6, 55.8, 61.8, 170.4. IR (neat, cm
-1
): 
υN3 = 2101, υC=O = 1734. MS (ES, pos. mode): m/z (%): 227 (M+H
+
, 100). Anal. 
Calcd for C10H18N4O2 (%): C, 53.08; H, 8.02; N, 24.76. Found (%): C, 52.77; H, 
8.17; N, 24.45. 
 
Ethyl 1-tert-pentyl-2-(azidomethyl)aziridine-2-carboxylate (18b) 
 
Yellow oil, yield 93%, Rf = 0.50 (petroleum ether/EtOAc 9/1). 
1
H NMR (300 
MHz, CDCl3): δ 0.91 (3H, t, J = 7.4 Hz, CCH2CH3), 0.97 (3H, s, CCH3), 0.99 
(3H, s, CCH3), 1.32 (3H, t, J = 7.2 Hz, OCH2CH3), 1.46 (1H, dq, J = 13.8 Hz, 7.3 
15 
Hz, CCH(H)CH3), 1.51 (1H, dq, J = 13.6 Hz, 7.5 Hz, CCH(H)CH3), 1.90 (1H, d, J 
= 1.1 Hz, NCH(H)), 2.50-2.51 (1H, m, NCH(H)), 3.26 (1H, d, J = 12.7 Hz, 
CH(H)N3), 3.70 (1H, d, J = 12.7 Hz, CH(H)N3), 4.19 (1H, dq, J = 11.0 Hz, 7.2 
Hz, OCH(H)CH3), 4.25 (1H, dq, J = 10.7 Hz, 7.2 Hz, OCH(H)CH3). 
13
C NMR 
(75 MHz, CDCl3): δ 8.8, 14.0, 24.0, 24.6, 32.1, 36.6, 42.5, 55.7, 57.0, 61.7, 170.7. 
IR (neat, cm
-1
): υN3 = 2101, υC=O = 1734. MS (ES, pos. mode): m/z (%): 241 
(M+H
+
, 100). Anal. Calcd for C11H20N4O2 (%): C, 54.98; H, 8.39; N, 23.32. 
Found (%): C, 54.61; H, 8.53; N, 23.14. 
 
Methyl 1-tert-butyl-2-(azidomethyl)aziridine-2-carboxylate (18c) 
 
Light yellow oil, yield 91%, Rf = 0.53 (hexane/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 1.09 (9H, s, C(CH3)3), 1.90 (1H, d, J = 1.1 Hz, NCH(H)), 2.47 (1H, s, 
NCH(H)), 3.29 (1H, d, J = 12.7 Hz, CH(H)N3), 3.67 (1H, d, J = 12.7 Hz, 
CH(H)N3), 3.77 (3H, s, OCH3). 
13
C NMR (75 MHz, CDCl3): δ 28.2, 32.0, 42.9, 
52.7, 54.6, 55.6, 61.8, 171.0. IR (neat, cm
-1
): υN3 = 2105, υC=O = 1740. MS (ES, 
pos. mode): m/z (%): 213 (M+H
+
, 100). Anal. Calcd for C9H16N4O2 (%): C, 50.93; 
H, 7.60; N, 26.40. Found (%): C, 50.64; H, 7.47; N, 26.51. 
 
Methyl 1-tert-pentyl-2-(azidomethyl)aziridine-2-carboxylate (18d) 
 
Yellow oil, yield 64%, Rf = 0.25 (petroleum ether/Et2O 9/1). 
1
H NMR (300 MHz, 
CDCl3): δ 0.91 (3H, t, J = 7.6 Hz, CCH2CH3), 0.96 (3H, s, CCH3), 0.98 (3H, s, 
CCH3), 1.45 (1H, dq, J = 13.6 Hz, 7.3 Hz, CCH(H)CH3), 1.50 (1H, dq, J = 13.6 
Hz, 7.7 Hz, CCH(H)CH3), 1.92 (1H, d, J = 1.4 Hz, NCH(H)), 2.50-2.51 (1H, m, 
NCH(H)), 3.28 (1H, d, J = 12.7 Hz, CH(H)N3), 3.69 (1H, d, J = 12.7 Hz, 
CH(H)N3), 3.77 (3H, s, OCH3). 
13
C NMR (75 MHz, CDCl3): δ 8.8, 23.9, 24.5, 
32.1, 36.6, 42.2, 52.6, 55.6, 56.9, 171.3. IR (neat, cm
-1
): υN3 = 2100, υC=O = 1732. 
MS (ES, pos. mode): m/z (%): 227 (M+H
+
, 100). Anal. Calcd for C10H18N4O2 
(%): C, 53.08; H, 8.02; N, 24.76. Found (%): C, 52.85; H, 8.24; N, 24.59. 
 
Synthesis of alkyl 2-(phenoxymethyl)aziridine-2-carboxylates 19a-b 
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As a representative example, the synthesis of ethyl 1-tert-butyl-2-
(phenoxymethyl)aziridine-2-carboxylate (19a) is described here. Ethyl 1-tert-
butyl-2-(bromomethyl)aziridine-2-carboxylate (14a) (80 mg, 0.3 mmol) was 
added to a mixture of phenol (57 mg, 0.6 mmol) and K2CO3 (168 mg, 1.2 mmol) 
in DMSO (4 mL) and the reaction mixture was heated at 60 °C for 8 h. After 
cooling, the reaction mixture was poured into water (15 mL) and extracted with 
Et2O (3 × 15 mL). The combined organic extracts were washed with brine (2 × 15 
mL), saturated NaOH (aq.) solution (2 × 10 mL) and water (15 mL). Drying 
(MgSO4), filtration, evaporation of the solvent under reduced pressure and 
purification by preparative TLC on silica gel (petroleum ether/EtOAc 9/1) 
afforded 2-(phenoxymethyl)aziridine 19a in 60% yield. 
 
Ethyl 1-tert-butyl-2-(phenoxymethyl)aziridine-2-carboxylate (19a) 
 
Yellow oil, yield 60%, Rf = 0.33 (petroleum ether /EtOAc 9/1). 
1
H NMR (300 
MHz, CDCl3): δ 1.11 (9H, s, (CH3)3), 1.25 (3H, t, J = 7.2 Hz, CH2CH3), 1.92 (1H, 
d, J = 1.1 Hz, NCH(H)), 2.49 (1H, s, NCH(H)), 3.72 (1H, d, J = 9.4 Hz, 
CCH(H)O), 4.18 (1H, dq, J = 10.7 Hz, 7.2 Hz, OCH(H)CH3), 4.22 (1H, dq, J = 
10.7 Hz, 7.2 Hz, OCH(H)CH3), 4.60 (1H, d, J = 9.6 Hz, CCH(H)O), 6.86-6.97 
(3H, m, 3×CHarom), 7.23-7.30 (2H, m, 2×CHarom). 
13
C NMR (75 MHz, CDCl3): δ 
14.1, 28.2, 31.7, 43.6, 54.6, 61.5, 72.1, 114.9, 121.1, 129.5, 158.7, 170.4. IR (neat, 
cm
-1
): υC=O = 1730. MS (ES, pos. mode): m/z (%): 278 (M+H
+
, 100). Anal. Calcd 
for C16H23NO3 (%): C, 69.29; H, 8.36; N, 5.05. Found (%): C, 69.43; H, 8.61; N, 
4.76. 
 
Ethyl 1-tert-pentyl-2-(phenoxymethyl)aziridine-2-carboxylate (19b) 
 
Yellow oil, yield 67%, Rf = 0.19 (petroleum ether/EtOAc 9/1). 
1
H NMR (300 
MHz, CDCl3): δ 0.94 (3H, t, J = 7.4 Hz, CCH2CH3), 0.97 (3H, s, CCH3), 1.00 
(3H, s, CCH3), 1.25 (3H, t, J = 7.2 Hz, OCH2CH3), 1.45-1.59 (2H, m, CCH2CH3), 
1.93 (1H, d, J = 1.4 Hz, NCH(H)), 2.53 (1H, s, NCH(H)), 3.70 (1H, d, J = 9.4 Hz, 
CCH(H)O), 4.18 (1H, dq, J = 10.7 Hz, 7.2 Hz, OCH(H)CH3), 4.21 (1H, dq, J = 
11.0 Hz, 7.2 Hz, OCH(H)CH3), 4.61 (1H, dd, J = 9.4 Hz, 0.8 Hz, CCH(H)O), 
6.85-6.97 (3H, m, 3×CHarom), 7.23-7.30 (2H, m, 2×CHarom). 
13
C NMR (75 MHz, 
17 
CDCl3): δ 8.8, 14.1, 24.0, 24.5, 31.9, 36.4, 42.8, 56.9, 61.4, 72.1, 114.9, 121.1, 
129.5, 158.8, 170.7. IR (neat, cm
-1
): υC=O = 1730. MS (ES, pos. mode): m/z (%): 
292 (M+H
+
, 100). Anal. Calcd for C17H25NO3 (%): C, 70.07; H, 8.65; N, 4.81. 
Found (%): C, 69.91; H, 8.83; N, 4.54. 
 
Synthesis of ethyl 1-tert-butyl-3-cyanoazetidine-3-carboxylate (21a) 
 
A solution of ethyl 1-tert-butyl-3-bromoazetidine-3-carboxylate (15a) (132 mg, 
0.5 mmol) and potassium cyanide (65 mg, 1 mmol) in DMSO (2 mL) was heated 
at 60 °C for 4 h. After cooling, the reaction mixture was poured into water (20 
mL) and extracted with Et2O (3 × 15 mL). The combined organic extracts were 
washed with brine (2 × 15 mL) and water (15 mL). Drying (MgSO4), filtration, 
evaporation of the solvent under reduced pressure and purification by preparative 
TLC on silica gel (petroleum ether/EtOAc 8/2) afforded 3-cyanoazetidine 21a in 
79% yield. Yellow oil, Rf = 0.43 (petroleum ether/EtOAc 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 0.96 (9H, s, C(CH3)3), 1.34 (3H, t, J = 7.2 Hz, CH2CH3), 3.62 
(2H, d, J = 7.2 Hz, CH(H)NCH(H)), 3.72 (2H, d, J = 7.4 Hz, CH(H)NCH(H)), 
4.30 (2H, q, J = 7.2 Hz, CH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 14.0, 23.8, 34.6, 
52.2, 54.3, 63.2, 119.0, 167.0. IR (neat, cm
-1
): υCN = 2246 (weak), υC=O = 1742. 
MS (ES, pos. mode): m/z (%): 211 (M+H
+
, 100). Anal. Calcd for C11H18N2O2 
(%): C, 62.83; H, 8.63; N, 13.32. Found (%): C, 62.91; H, 8.79; N, 13.01. 
 
Synthesis of alkyl 3-thiocyanoazetidine-3-carboxylates 22a-b 
 
As a representative example, the synthesis of ethyl 1-tert-butyl-3-
thiocyanoazetidine-3-carboxylate (22a) is described here. A solution of ethyl 1-
tert-butyl-3-bromoazetidine-3-carboxylate (15a) (94 mg, 0.36 mmol) and 
potassium thiocyanate (52 mg, 0.53 mmol) in DMSO (2 mL) was heated at 60 °C 
for 3 h. After cooling, the reaction mixture was poured into water (15 mL) and 
extracted with Et2O (3 × 20 mL). The combined organic extracts were washed 
with brine (2 × 15 mL) and water (15 mL). Drying (MgSO4), filtration, 
evaporation of the solvent under reduced pressure and purification by preparative 
TLC on silica gel (petroleum ether/Et2O 7/3) afforded 3-thiocyanoazetidine 22a in 
59% yield. 
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Ethyl 1-tert-butyl-3-thiocyanoazetidine-3-carboxylate (22a) 
 
Yellow oil, yield 59%, Rf = 0.17 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.98 (9H, s, C(CH3)3), 1.35 (3H, t, J = 7.2 Hz, OCH2CH3), 3.44 (2H, d, 
J = 8.8 Hz, CH(H)NCH(H)), 3.83 (2H, d, J = 8.8 Hz, CH(H)NCH(H)), 4.32 (2H, 
q, J = 7.2 Hz, OCH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 14.1, 24.0, 47.4, 52.4, 
55.7, 63.0, 109.9, 169.2. IR (neat, cm
-1
): υSCN = 2157, υC=O = 1736. MS (ES, pos. 
mode) m/z (%): 243 (M+H
+
, 100). Anal. Calcd for C11H18N2O2S (%): C, 54.52; H, 
7.49; N, 11.56. Found (%): C, 54.27; H, 7.64; N, 11.64. 
 
Ethyl 1-tert-pentyl-3-thiocyanoazetidine-3-carboxylate (22b) 
 
Yellow oil, yield 83%, Rf = 0.21 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.85 (3H, t, J = 7.4 Hz, CCH2CH3), 0.90 (6H, s, C(CH3)2), 1.25 (2H, q, 
J = 7.7 Hz, CCH2CH3), 1.35 (3H, t, J = 7.2 Hz, OCH2CH3), 3.43 (2H, d, J = 8.8 
Hz, CH(H)NCH(H)), 3.82 (2H, d, J = 9.4 Hz, CH(H)NCH(H)), 4.31 (2H, q, J = 
7.2 Hz, OCH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 8.5, 14.1, 20.2, 31.4, 47.9, 
54.8, 55.6, 63.0, 110.0, 169.3. IR (neat, cm
-1
): υSCN = 2157, υC=O = 1736. MS (ES, 
pos. mode) m/z (%): 257 (M+H
+
, 100). Anal. Calcd for C12H20N2O2S (%): C, 
56.22; H, 7.86; N, 10.93. Found (%): C, 56.09; H, 8.01; N, 10.64. 
 
Synthesis of alkyl 3-azidoazetidine-3-carboxylates 23a-c 
 
As a representative example, the synthesis of ethyl 1-tert-pentyl-3-azidoazetidine-
3-carboxylate (23b) is described here. A solution of ethyl 1-tert-pentyl-3-
bromoazetidine-3-carboxylate (15b) (111 mg, 0.4 mmol) and sodium azide (52 
mg, 0.8 mmol) in DMSO (2 mL) was heated at 60 °C for 3 h. After cooling, the 
reaction mixture was poured into water (15 mL) and extracted with Et2O (3 × 15 
mL). The combined organic extracts were washed with brine (2 × 15 mL) and 
water (10 mL). Drying (MgSO4), filtration, evaporation of the solvent under 
reduced pressure and purification by preparative TLC on silica gel (petroleum 
ether/Et2O 8/2) afforded 3-azidoazetidine 23b in 98% yield.  
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Ethyl 1-tert-butyl-3-azidoazetidine-3-carboxylate (23a) 
 
Yellow oil, yield 86%, Rf = 0.18 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.99 (9H, s, C(CH3)3), 1.34 (3H, t, J = 7.2 Hz, CH2CH3), 3.32 (2H, d, J 
= 7.4 Hz, CH(H)NCH(H)), 3.70 (2H, d, J = 7.4 Hz, CH(H)NCH(H)), 4.29 (2H, q, 
J = 7.2 Hz, OCH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 14.2, 24.0, 52.2, 54.4, 
59.3, 62.4, 170.0. IR (neat, cm
-1
): υN3 = 2109, υC=O = 1737. MS (ES, pos. mode): 
m/z (%): 227 (M+H
+
, 100). Anal. Calcd for C10H18N4O2 (%): C, 53.08; H, 8.02; 
N, 24.76. Found (%): C, 52.74; H, 8.31; N, 24.90. 
 
Ethyl 1-tert-pentyl-3-azidoazetidine-3-carboxylate (23b) 
 
Yellow oil, yield 98%, Rf = 0.24 (petroleum ether/Et2O 8/2). 
1
H NMR (300 MHz, 
CDCl3): δ 0.85 (3H, t, J = 7.4 Hz, CCH2CH3), 0.91 (6H, s, C(CH3)2), 1.27 (2H, q, 
J = 7.4 Hz, CCH2CH3), 1.34 (3H, t, J = 7.2 Hz, OCH2CH3), 3.30 (2H, dd, J = 7.2 
Hz, 1.4 Hz, CH(H)NCH(H)), 3.70 (2H, dd, J = 7.3 Hz, 1.4 Hz, CH(H)NCH(H)), 
4.28 (2H, q, J = 7.2 Hz, OCH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 8.6, 14.2, 
20.0, 31.5, 54.3, 54.6, 59.7, 62.3, 170.0. IR (neat, cm
-1
): υN3 = 2108, υC=O = 1738. 
MS (ES, pos. mode): m/z (%): 241 (M+H
+
, 100). Anal. Calcd for C11H20N4O2 
(%): C, 54.98; H, 8.39; N, 23.32. Found (%): C, 54.59; H, 8.53; N, 23.64. 
 
Methyl 1-tert-butyl-3-azidoazetidine-3-carboxylate (23c) 
 
Yellow oil, yield 79%, Rf = 0.22 (petroleum ether/EtOAc 7/3). 
1
H NMR (300 
MHz, CDCl3): δ 0.99 (9H, s, C(CH3)3), 3.33 (2H, d, J = 7.4 Hz, CH(H)NCH(H)), 
3.70 (2H, d, J = 7.4 Hz, CH(H)NCH(H)), 3.84 (3H, s, OCH3). 
13
C NMR (75 MHz, 
CDCl3): δ 24.0, 52.2, 53.2, 54.5, 59.4, 170.5. IR (neat, cm
-1
): υN3 = 2109, υC=O = 
1740. MS (ES, pos. mode): m/z (%): 213 (M+H
+
, 100). Anal. Calcd for 
C9H16N4O2 (%): C, 50.93; H, 7.60; N, 26.40. Found (%): C, 50.79; H, 7.69; N, 
26.21. 
 
Synthesis of alkyl 3-phenoxyazetidine-3-carboxylates 20a-b 
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As a representative example, the synthesis of ethyl 1-tert-pentyl-3-
phenoxyazetidine-3-carboxylate (20b) is described here. Ethyl 1-tert-pentyl-3-
bromoazetidine-3-carboxylate (15b) (83 mg, 0.3 mmol) was added to a mixture of 
phenol (70 mg, 0.75 mmol) and K2CO3 (206 mg, 1.5 mmol) in DMSO (2 mL) and 
the reaction mixture was heated at 60 °C for 8 h. After cooling, the reaction 
mixture was poured into water (15 mL) and extracted with Et2O (3 × 15 mL). The 
combined organic extracts were washed with brine (2 × 15 mL), saturated NaOH 
(aq.) solution (2 × 10 mL) and water (15 mL). Drying (MgSO4), filtration, 
evaporation of the solvent under reduced pressure and purification by preparative 
TLC on silica gel (petroleum ether/Et2O 7/3) afforded 3-phenoxyazetidine 20b in 
81% yield. 
 
Ethyl 1-tert-butyl-3-phenoxyazetidine-3-carboxylate (20a) 
 
Yellow oil, yield 36%, Rf = 0.25 (petroleum ether/Et2O 1/1). 
1
H NMR (300 MHz, 
CDCl3): δ 1.00 (9H, s, C(CH3)3), 1.15 (3H, t, J = 7.2 Hz, CH2CH3), 3.51 (2H, d, J 
= 9.1 Hz, CH(H)NCH(H)), 3.88 (2H, d, J = 9.1 Hz, CH(H)NCH(H)), 4.21 (2H, q, 
J = 7.2 Hz, OCH2CH3), 6.65-6.69 (2H, m, 2×CHarom), 6.93-6.98 (1H, m, CHarom), 
7.20-7.27 (2H, m, 2×CHarom). 
13
C NMR (75 MHz, CDCl3): δ 14.1, 24.1, 52.2, 
55.0, 61.9, 73.8, 115.2, 121.5, 129.6, 155.4, 171.4. IR (neat, cm
-1
): υC=O = 1736. 
MS (ES, pos. mode): m/z (%): 278 (M+H
+
, 100). Anal. Calcd for C16H23NO3 (%): 
C, 69.29; H, 8.36; N, 5.05. Found (%): C, 69.02; H, 8.59; N, 4.83. 
 
Ethyl 1-tert-pentyl-3-phenoxyazetidine-3-carboxylate (20b) 
 
Yellow oil, yield 81%, Rf = 0.27 (petroleum ether/Et2O 7/3). 
1
H NMR (300 MHz, 
CDCl3): δ 0.85 (3H, t, J = 7.4 Hz, CCH2CH3), 0.92 (6H, s, C(CH3)2), 1.15 (3H, t, 
J = 7.2 Hz, OCH2CH3), 1.30 (2H, q, J = 7.4 Hz, CCH2CH3), 3.51 (2H, d, J = 8.0 
Hz, CH(H)NCH(H)), 3.86 (2H, d, J = 8.0 Hz, CH(H)NCH(H)), 4.21 (2H, q, J = 
7.2 Hz, OCH2CH3), 6.66-6.69 (2H, m, 2×CHarom), 6.93-6.98 (1H, m, CHarom), 
7.21-7.26 (2H, m, 2×CHarom). 
13
C NMR (75 MHz, CDCl3): δ 8.7, 14.1, 20.0, 31.5, 
54.7, 54.8, 61.8, 74.1, 115.2, 121.5, 129.6, 155.5, 171.4. IR (neat, cm
-1
): υC=O = 
1736. MS (ES, pos. mode): m/z (%): 292 (M+H
+
, 100). Anal. Calcd for 
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C17H25NO3 (%): C, 70.07; H, 8.65; N, 4.81. Found (%): C, 70.34; H, 8.40; N, 
4.60. 
 
Synthesis of ethyl 1-tert-pentyl-2-(aminomethyl)aziridine-2-carboxylate (24b) 
 
To a solution of ethyl 1-tert-pentyl-2-(azidomethyl)aziridine-2-carboxylate (18b) 
(70 mg, 0.29 mmol) in EtOH (7 mL), Pd (7 mg, 10 wt% on carbon) was added 
and the reaction mixture was stirred under H2 atmosphere (4 bar) at room 
temperature for 3 h. Subsequently, the reaction mixture was filtered over Celite
®
 
and the filter cake was washed with small portions of EtOH. Evaporation of the 
solvent under reduced pressure and purification by preparative TLC on silica gel 
(CH2Cl2/MeOH 100/5) afforded 2-(aminomethyl)aziridine 24b. Yellow oil, yield 
68%, Rf = 0.27 (CH2Cl2/MeOH 9/1). 
1
H NMR (300 MHz, CDCl3): δ 0.92 (3H, t, J 
= 7.6 Hz, CCH2CH3), 0.94 (3H, s, CCH3), 0.98 (3H, s, CCH3), 1.30 (3H, t, J = 7.2 
Hz, OCH2CH3), 1.48 (1H, dq, J = 13.6 Hz, 7.4 Hz, CCH(H)CH3), 1.51 (1H, dq, J 
= 13.4 Hz, 7.4 Hz, CCH(H)CH3), 1.78 (1H, d, J = 1.1 Hz, CH(H)N), 1.86 (2H, br 
s, NH2), 2.41 (1H, d, J = 1.4 Hz, CH(H)N), 2.87 (1H, d, J = 13.8 Hz, CH(H)NH2), 
2.89 (1H, d, J = 13.8 Hz, CH(H)NH2), 4.16 (1H, dq, J = 10.7 Hz, 7.2 Hz, 
OCH(H)CH3), 4.22 (1H, dq, J = 10.7 Hz, 7.2 Hz, OCH(H)CH3). 
13
C NMR (75 
MHz, CDCl3): δ 8.9, 14.1, 23.8, 24.5, 31.4, 36.7, 46.9, 56.5, 61.3, 172.1. IR (neat, 
cm
-1
): υNH2 = 3381 (weak), υC=O = 1724. MS (ES, pos. mode): m/z (%): 215 
(M+H
+
, 100). Anal. Calcd for C11H22N2O2 (%): C, 61.65; H, 10.35; N, 13.07. 
Found (%): C, 61.27; H, 10.62; N, 12.91. 
 
Synthesis of alkyl 2-(tert-butoxycarbonylaminomethyl)aziridine-2-carboxylates 
25b-c 
 
As a representative example, the synthesis of methyl 1-tert-butyl-2-(tert-
butoxycarbonylaminomethyl)aziridine-2-carboxylate (25c) is described here. To a 
solution of methyl 1-tert-butyl-2-(azidomethyl)aziridine-2-carboxylate (18c) (65 
mg, 0.31 mmol) in degassed CH3CN (8 mL), Pd (6.5 mg, 10 wt% on carbon) and 
di-tert-butyl dicarbonate (334 mg, 1.53 mmol) were added and the reaction 
mixture was stirred under H2 atmosphere (10 bar) at room temperature for 3 h. 
Subsequently, the reaction mixture was filtered over Celite
®
 and the filter cake 
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was washed with small portions of CH3CN. Evaporation of the solvent under 
reduced pressure and purification by flash chromatography on silica gel 
(hexane/EtOAc 9/1) afforded aziridine 25c in 76% yield. 
 
Ethyl 1-tert-pentyl-2-(tert-butoxycarbonylaminomethyl)aziridine-2-carboxylate 
(25b) 
 
Light yellow oil, yield 49%, Rf = 0.13 (hexane/EtOAc 9/1). 
1
H NMR (300 MHz, 
CDCl3): δ 0.91 (3H, t, J = 7.7 Hz, CCH2CH3), 0.96 (3H, s, NCCH3), 0.97 (3H, s, 
CCH3), 1.29 (3H, t, J = 7.2 Hz, OCH2CH3), 1.40-1.50 (2H, m, CCH2CH3), 1.43 
(9H, s, NCCH3), 1.86 (1H, d, J = 1.1 Hz, NCH(H)), 2.39 (1H, s, NCH(H)), 3.30 
(1H, dd, J = 13.8 Hz, 4.4 Hz, CH(H)NH), 3.60 (1H, d, J = 13.8 Hz, 7.7 Hz, 
CH(H)NH), 4.18 (2H, m, OCH2CH3), 4.90 (1H, br s, NH). 
13
C NMR (75 MHz, 
CDCl3): δ 8.8, 14.0, 24.2, 24.6, 28.5, 31.0, 36.7, 42.3, 43.5, 56.6, 61,4, 79.3, 
155.9, 171.6. IR (neat, cm
-1
): υNH = 3382, υC=O = 1717. MS (ES, pos. mode): m/z 
(%): 315 (M+H
+
, 100). Anal. Calcd for C16H30N2O4 (%): C, 61.12; H, 9.62; N, 
8.91. Found (%): C, 61.39; H, 9.51; N, 8.86. 
 
Methyl 1-tert-butyl-2-(tert-butoxycarbonylaminomethyl)aziridine-2-carboxylate 
(25c) 
 
Light yellow oil, yield 76%, Rf = 0.07 (hexane/EtOAc 9/1). 
1
H NMR (300 MHz, 
CDCl3): δ 1.07 (9H, s, NC(CH3)3), 1.44 (9H, s, OC(CH3)3), 1.87 (1H, d, J = 1.1 
Hz, NCH(H)), 2.34 (1H, s, NCH(H)), 3.33 (1H, dd, J = 13.8 Hz, 4.4 Hz, 
CH(H)NH), 3.57 (1H, dd, J = 13.8 Hz, 7.2 Hz, CH(H)NH), 3.72 (3H, s, OCH3), 
4.93 (1H, br s, NH). 
13
C NMR (75 MHz, CDCl3): δ 28.4, 28.5, 31.0, 42.9, 43.6, 
52.4, 54.3, 79.3, 155.9, 172.0. IR (neat, cm
-1
): υNH = 3382, υC=O = 1718. MS (ES, 
pos. mode): m/z (%): 287 (M+H
+
, 100). Anal. Calcd for C14H26N2O4 (%): C, 
58.72; H, 9.15; N, 9.78. Found (%): C, 58.59; H, 9.38; N, 9.59. 
 
Synthesis of ethyl 1-tert-butyl-3-aminoazetidine-3-carboxylate (26a) 
 
To a solution of ethyl 1-tert-butyl-3-azidoazetidine-3-carboxylate (23a) (52 mg, 
0.23 mmol) in EtOH (5 mL), Pd (5.2 mg, 10 wt% on carbon) was added and the 
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reaction mixture was stirred under H2 atmosphere (4 bar) at room temperature for 
3 h. Subsequently, the reaction mixture was filtered over Celite
®
 and the filter 
cake was washed with small portions of EtOH. Evaporation of the solvent under 
reduced pressure and purification by preparative TLC on silica gel (petroleum 
ether/EtOAc 1/1) afforded 3-aminoazetidine 26a in 78% yield. Yellow oil, Rf = 
0.10 (petroleum ether/EtOAc 1/1). 
1
H NMR (300 MHz, CDCl3): δ 0.99 (9H, s, 
C(CH3)3), 1.31 (3H, t, J = 7.2 Hz, CH2CH3), 2.37 (2H, br s, NH2), 3.10 (2H, d, J = 
8.3 Hz, NCH(H)), 3.72 (2H, d, J = 8.3 Hz, NCH(H)), 4.22 (2H, q, J = 7.2 Hz, 
OCH2CH3). 
13
C NMR (75 MHz, CDCl3): δ 14.3, 24.0, 52.2, 53.1, 57.7, 61.5, 
173.9. IR (neat, cm
-1
): υNH2 = 3376 (weak), υC=O = 1730. MS (ES, pos. mode): m/z 
(%): 201 (M+H
+
, 100). Anal. Calcd for C10H20N2O2 (%): C, 59.97; H, 10.07; N, 
13.99. Found (%): C, 59.61; H, 10.17; N, 13.64. 
 
Synthesis of alkyl 3-azidoazetidine-3-carboxylic acids 27a-b 
 
As a representative example, the synthesis of 1-tert-butyl-3-azidoazetidine-3-
carboxylic acid (27a) is described here. To a solution of ethyl 1-tert-butyl-3-
azidoazetidine-3-carboxylate (23a) (96 mg, 0.42 mmol) in MeOH (3 mL), 2N 
NaOH (aq.) solution (3 mL) was added dropwise at 0 °C and the reaction mixture 
was stirred at room temperature for 3 h. The reaction mixture was acidified with 
1N HCl aq. solution till pH=7 and the solvents were evaporated under reduced 
pressure. The residue was dissolved in H2O and purified by means of ion-
exchange chromatography on Dowex H
+
 (50 × 8‒100) by sequential elution with 
H2O and 1N NH4OH aq. solution. The eluted aqueous solution of the ammonium 
salt was neutralized with 2N HCl aq. solution and the solvent was evaporated 
under reduced pressure. The residue was taken up in CH2Cl2, filtered and 
evaporated under reduced pressure to afford carboxylic acid 27a in 90% yield. 
 
1-tert-Butyl-3-azidoazetidine-3-carboxylic acid (27a) 
 
Yellow viscous oil, yield 90%, Rf = 0.15 (CH2Cl2/MeOH 9/1). 
1
H NMR (300 
MHz, CD3OD): δ 1.34 (9H, s, C(CH3)3), 4.05 (2H, d, J = 11.0 Hz, 
CH(H)NCH(H)), 4.51 (2H, d, J = 11.6 Hz, CH(H)NCH(H)). 
13
C NMR (75 MHz, 
CD3OD): δ 24.2, 53.5, 55.6, 62.2, 176.5. IR (neat, cm
-1
): υOH = 3425, υN3 = 2121, 
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υC=O = 1623. MS (ES, pos. mode): m/z (%): 199 (M+H
+
, 100). Anal. Calcd for 
C8H14N4O2 (%): C, 48.47; H, 7.12; N, 28.26. Found (%): C, 48.09; H, 6.98; N, 
28.07. 
 
1-tert-Pentyl-3-azidoazetidine-3-carboxylic acid (27b) 
 
Yellow viscous oil, yield 76%, Rf = 0.21 (CH2Cl2/MeOH 9/1). 
1
H NMR (300 
MHz, CD3OD): δ 0.98 (3H, t, J = 7.7 Hz, CCH2CH3), 1.30 (6H, s, C(CH3)2), 1.27 
(2H, q, J = 7.7 Hz, CCH2CH3), 4.07 (2H, d, J = 11.0 Hz, CH(H)NCH(H)), 4.54 
(2H, d, J = 11.6 Hz, CH(H)NCH(H)). 
13
C NMR (75 MHz, CD3OD): δ 8.6, 20.0, 
31.5, 54.3, 54.6, 59.7, 170.0. IR (neat, cm
-1
): υOH = 3417, υN3 = 2102, υC=O = 1604. 
MS (ES, pos. mode): m/z (%): 213 (M+H
+
, 100). Anal. Calcd for C9H16N4O2 (%): 
C, 50.93; H, 7.60; N, 26.40. Found (%): C, 50.74; H, 7.78; N, 26.29. 
 
Synthesis of alkyl 3-aminoazetidine-3-carboxylic acids 28a-b 
 
As a representative example, the synthesis of 1-tert-pentyl-3-aminoazetidine-3-
carboxylic acid (28b) is described here. To a solution of 1-tert-pentyl-3-
azidoazetidine-3-carboxylic acid (27b) (60 mg, 0.3 mmol) in MeOH (12 mL), Pd 
(6 mg, 10 wt% on carbon) was added and the reaction mixture was stirred under 
H2 atmosphere (3 bar) at room temperature for 3 h. Subsequently, the reaction 
mixture was filtered over Celite
®
 and the filter cake was washed with small 
portions of MeOH. The solvent was evaporated under reduced pressure. The 
residue was dissolved in H2O and purified by means of ion-exchange 
chromatography on Dowex H
+
 (50 × 8‒100) by sequential elution with H2O and 
1N NH4OH aq. solution. The eluted aqueous solution of the ammonium salt was 
neutralized with 2N HCl aq. solution and the solvent was evaporated under 
reduced pressure. The residue was taken up in CH2Cl2, filtered and evaporated 
under reduced pressure to afford amino acid 28b in 80% yield. 
 
1-tert-Butyl-3-aminoazetidine-3-carboxylic acid (28a) 
 
Brown viscous oil, yield 76%, Rf = 0.02 (CH2Cl2/MeOH 9/1). 
1
H NMR (300 
MHz, CD3OD): δ 1.21 (9H, s, C(CH3)3), 3.75 (2H, d, J = 10.5 Hz, 
25 
CH(H)NCH(H)), 4.25 (2H, d, J = 10.5 Hz, CH(H)NCH(H)). 
13
C NMR (75 MHz, 
CD3OD): δ 23.5, 54.2, 59.1, 59.3, 176.4. IR (neat, cm
-1
): υOH,NH2 = 3379, υC=O = 
1650. MS (ES, pos. mode): m/z (%): 173 (M+H
+
, 100). Anal. Calcd for 
C8H16N2O2 (%): C, 55.79; H, 9.36; N, 16.27. Found (%): C, 55.51; H, 9.52; N, 
16.39. 
 
1-tert-Pentyl-3-aminoazetidine-3-carboxylic acid (28b) 
 
Brown viscous oil, yield 80%, Rf = 0.03 (CH2Cl2/MeOH 9/1). 
1
H NMR (300 
MHz, CD3OD): δ 0.96 (3H, t, J = 7.4 Hz, CCH2CH3), 1.21 (6H, s, C(CH3)2), 1.56 
(2H, q, J = 7.4 Hz, CCH2CH3), 3.72 (2H, d, J = 10.5 Hz, CH(H)NCH(H)), 4.24 
(2H, d, J = 9.9 Hz, CH(H)NCH(H)). 
13
C NMR (75 MHz, CD3OD): δ 8.6, 20.0, 
30.8, 54.8, 59.3, 61.5, 176.8. IR (neat, cm
-1
): υOH,NH2 = 3338, υC=O = 1625. MS 
(ES, pos. mode): m/z (%): 187 (M+H
+
, 100). Anal. Calcd for C9H18N2O2 (%): C, 
58.04; H, 9.74; N, 15.04. Found (%): C, 57.85; H, 9.87; N, 14.83. 
 
Results and discussion 
 
The synthesis of N-substituted alkyl 2-(aminomethyl)acrylates 12 via substitution 
reactions of alkyl 2-(bromomethyl)acrylates 11 with primary amines was 
performed under optimized conditions in analogy with literature procedures 
(Baraki et al. 1999; Habaue et al. 1997). Addition of alkyl 2-
(bromomethyl)acrylates 11 to a solution of primary amine and triethylamine in 
dichloromethane at 0 °C afforded ethyl and methyl 2-
[(alkylamino)methyl]acrylates 12 in excellent yields (Table 1). Subsequently, 
following a typical procedure for the bromination of functionalized allylamines 
(De Smaele et al. 2001), the amino group of alkyl 2-
[(alkylamino)methyl]acrylates 12 was protected by treatment with aqueous 
hydrobromic acid in dichloromethane to the corresponding hydrobromide salts. 
Subsequent bromination followed by neutralization of the reaction mixture with 
an aqueous NaHCO3 solution afforded the desired dibromopropanoates 13 in 
excellent yields (Table 1). 
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Table 1 Synthesis and bromination of alkyl 2-(aminomethyl)acrylates 12 
1) 1.1 equiv HBr
CH2Cl2/H2O
0 oC, 30 min
2) 1 equiv Br2
CH2Cl2, r.t., 5 - 14 h
3) NaHCO3, EtOAc
COOR1
NH
COOR1
NH
Br
Br
13 (90-98%)
1.02 equiv R2NH2
1.04 equiv Et3N
COOR1
Br
CH2Cl2, 0 
oC, 30 min
11 12 (91-98%)
R2 R2
 
Entry Substrate R
1
 R
2
 12 (%) 13 (%)
a 
1 11a Et t-Bu 12a (97) 13a (98) 
2 11a Et t-Pentyl 12b (91) 13b (97) 
3 11b Me t-Bu 12c (94) 13c (90) 
4 11b Me t-Pentyl 12d (98) 13d (97) 
a
 Values between parentheses indicate yields of isolated products 
 
With the targeted dibromo amino esters 13 in hand, their ring closure upon 
treatment under basic conditions to the desired aziridines 14 and/or azetidines 15 
was investigated. After extensive screening of different bases, solvents, reaction 
temperatures and reaction times, it was found that a clean conversion of dibromo 
amines 13 to the aziridines 14 as major products together with the azetidines 15 as 
minor compounds could be achieved by using K2CO3 in acetonitrile at 60 °C. 
However, the yields of the isolated aziridines 14 and azetidines 15 were low after 
purification by flash chromatography on silicagel as, apparently, these 
azaheterocycles partly decompose on column (Table 2, entry 1). To our 
satisfaction, good overall yields of the targeted isolated aziridines 14 (44-54%) 
and azetidines 15 (24-33%) were obtained via separation by preparative TLC up 
to 1 g scale (Table 2, entries 2-5). 
It was envisioned that aziridines 14 are the kinetic cyclization products, while 
azetidines 15 result from a thermodynamical equilibration. The isomerization of 
2-(halomethyl)aziridines to 3-haloazetidines, although only in some cases 
observable for 2-(chloromethyl)aziridines which lack a second substituent at the 
2-position, was explained via the intermediacy of a bicyclic 
azonia[1.1.0]bicyclobutane I and eventually the corresponding carbenium ion II, 
followed by recombination with the initially expelled halide to give 3-
haloazetidines or 2-(halomethyl)aziridines (Gaertner 1970; Higgins and Kidd 
1998). In order to experimentally prove this isomerization of aziridine 14 to 
azetidine 15, alkyl 2-(bromomethyl)aziridine-2-carboxylates 14 were heated under 
several conditions similar to the reaction conditions used in the preparation of 
azetidines 15 from acyclic dibromo amino esters 13 (Table 3). 
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Table 2 Synthesis of alkyl aziridine-2-carboxylates 14 and alkyl azetidine-3-carboxylates 15 
COOR1
NH
Br
Br
N
COOR1Br
R2
N
COOR1
Br
R2
14 (44-54%)
1.5 equiv K2CO3
CH3CN, 60 
oC, 8 - 19 h
15 (24-33%)

R2
13a (R1 = Et, R2 = t-Bu)
13b (R1 = Et, R2 = t-Pentyl)
13c (R1 = Me, R2 = t-Bu)
13d (R1 = Me, R2 = t-Pentyl)  
Entry Substrate Reaction time (h) Result (%)
a,b 
1 13a 19 14a (19)
a
 + 15a (13)
a 
2 13a 19 14a (50)
b
 + 15a (33)
b
 
3 13b 12 14b (54)
b
 + 15b (24)
b
 
4 13c 8 14c (44)
b
 + 15c (25)
b
 
5 13d 18 14d (54)
b
 + 15d (26)
b
 
a
 Values between parentheses indicate yields of isolated products after purification by flash 
chromatography 
b
 Values between parentheses indicate yields of isolated products after purification by preparative 
TLC 
 
Table 3 Isomerization of 2-(bromomethyl)aziridines 14 to 3-bromoazetidines 15 
N
R2
COOR1
Br
N
COOR1Br
R2
14a (R1 = Et, R2 = t-Bu)
14b (R1 = Et, R2 = t-Pentyl)
14c (R1 = Me, R2 = t-Bu)
14d (R1 = Me, R2 = t-Pentyl)
15 (45-50%)
(see table)
I
N
R2
II
COOR1
N
R2
COOR1
 
Entry Substrate Reaction conditions Result 
1 14a CH3CN, 60 ºC, 3 h No reaction 
2 14a CH3CN, Δ, 15 h Decomposition 
3 14a 1 equiv KBr, CH3CN, 60 ºC, 24 h Decomposition 
4 14a DMSO, 55 ºC, 24 h 14a:15a = 2:1
a 
5 14a DMSO, 55 ºC, 24 h + 65 ºC, 6 h 14a:15a = 1:2.8
a 
6 14a DMSO, 70 ºC, 18 h 15a (45%)
b 
7 14b DMSO, 70 ºC, 45 h 15b (45%)
 b
 
8 14c DMSO, 70 ºC, 5 h 15c (45%)
 b
 
9 14d DMSO, 70 ºC, 5 h 15d (50%)
 b
 
10 14a 1 equiv KBr, DMSO, 70 °C, 18 h 15a (26%)
b
 
11 14a DMSO/H2O 1/1, 70 °C, 48 h Decomposition 
12 14a 1 equiv KBr, DMSO/H2O 1/1, 70 °C, 48 h Decomposition 
a
 Ratio determined by 
1
H NMR analysis 
b
 Values between parentheses indicate yields of isolated products 
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Heating of aziridine 14a in acetonitrile at 60 °C for 3 h gave no reaction (entry 1), 
while prolonged heating in acetonitrile at 60 °C in the presence of KBr, which is 
formed in situ during the cyclization of 13, resulted in decomposition to 
unidentified compounds after 24 h (entry 3). Nevertheless, a satisfactory 
isomerization of aziridine 14a to azetidine 15a was observed upon heating in 
DMSO, giving a mixture of 14a and 15a in a 2:1 ratio (
1
H NMR analysis) at 55 
°C after 24 h. The latter mixture further isomerized to 14a and 15a in a 1:2.8 ratio 
after additional heating at 65 °C for 6 h. After raising the temperature to 70 °C, 
full isomerization of aziridines 14a-d to azetidines 15a-d was obtained within 45 
h with 45–50% yield (Table 3, entries 6-9). Attempts to improve the outcome of 
the isomerization reaction by adding KBr resulted in a lower yield of 26% of 
azetidine 15a, while addition of water to the reaction (Table 3, entries 11-12) 
slowed down the isomerization and eventually led to total decomposition. 
 
Introduction of new functional groups in alkyl aziridine-2-carboxylates 14 and 
alkyl azetidine-3-carboxylates 15 in particular, would highly enrich the chemistry 
of these important classes of α- and β-amino acid derivatives. Therefore, the 
potential of the synthesized alkyl 2-(bromomethyl)aziridine-2-carboxylates 14 and 
alkyl 3-bromoazetidine-3-carboxylates 15 for further functionalization via 
substitution reactions with C-, S-, N- and O-nucleophiles was investigated (Tables 
4 and 5).
 
Treatment of alkyl 2-(bromomethyl)aziridine-2-carboxylates 14a-c with 
potassium cyanide in DMSO at 60 °C for 3 – 4 h uneventfully afforded the 
corresponding alkyl 2-(cyanomethyl)aziridine-2-carboxylates 16a-c in 47 – 57% 
yield (Table 4, entries 1-3). Few 2-(cyanomethyl)aziridines can be found in the 
literature (Gaertner 1970; Subbaraj et al. 1989; Antunes et al. 2007; Vedejs et al. 
2003; Krasnova et al. 2005), and some have been used recently for the synthesis 
of biologically relevant N-(2-cyanocyclopropyl)benzimidates (D’hooghe et al. 
2006a), 2-aminocyclopropanecarbonitriles (Mangelinckx et al. 2009), 4-amino-2-
butenenitriles (D’hooghe et al. 2007a, 2007b), 3,4-diaminobutanenitriles 
(D’hooghe et al. 2007a), and 2-aminopentanedinitriles (D’hooghe et al. 2008). 
Ethyl 2-(thiocyanomethyl)aziridine-2-carboxylates 17a-b were synthesized in 
moderate yield (44 – 48%) utilizing potassium thiocyanate in DMF at 70 °C due 
to the formation of some unidentified reaction products which were present in the 
crude reaction mixture (Table 4, entries 4-5). Only one report on the synthesis of 
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2-(thiocyanomethyl)aziridines, which were used for an intramolecular cyclisation 
to 2-iminothiazolidines, has been made (D’hooghe et al. 2005b). 
 
Table 4 Reactions of alkyl 2-(bromomethyl)aziridines 14 with different nucleophiles 
N
COOR1Nu
R2
N
COOR1
Nu
R2
16 (Nu = CN)
17 (Nu = SCN)
18 (Nu = N3)
19 (Nu = OPh)
20 (Nu = OPh)
N
COOR1
Br
R2
(see table)
14a (R1 = Et, R2 = t-Bu)
14b (R1 = Et, R2 = t-Pentyl)
14c (R1 = Me, R2 = t-Bu)
14d (R1 = Me, R2 = t-Pentyl)  
Entry Substrate Reaction conditions Result (%)
a 
1 14a 1 equiv KCN, DMSO, 60 ºC, 3 h 16a (47) 
2 14b 1 equiv KCN, DMSO, 60 ºC, 4 h 16b (54) 
3 14c 1 equiv KCN, DMSO, 60 ºC, 4 h 16c (57) 
4 14a 2 equiv KSCN, DMF, 70 ºC, 2 h 17a (48) 
5 14b 2 equiv KSCN, DMF, 70 ºC, 6 h 17b (44) 
6 14a 2 equiv NaN3, DMSO, 60 ºC, 1.5 h 18a (58) 
7 14b 2 equiv NaN3, DMSO, 60 ºC, 2 h 18b (93) 
8 14c 2 equiv NaN3, DMSO, 60 ºC, 3 h 18c (91) 
9 14d 2 equiv NaN3, DMSO, 60 ºC, 3 h 18d (64) 
10 14a 2.2 equiv PhOH, 5 equiv K2CO3 
acetone/DMF 1/1, Δ, 125 h 
19a (10) 
11 14b 2.2 equiv PhOH, 5 equiv K2CO3 
acetone/DMF 1/1, Δ, 160 h 
- 
12 14a 2 equiv PhOH, 4 equiv K2CO3 
DMSO, 60 ºC, 8 h 
19a (60) + 20a (5) 
13 14b 2 equiv PhOH, 4 equiv K2CO3 
DMSO, 60 ºC, 5 h 
19b (34) + 20b (4) 
14 14b 3 equiv PhOH, 6 equiv K2CO3 
DMSO, 60 ºC, 16 h 
19b (67) 
a
 Values between parentheses indicate yields of isolated products 
 
Alkyl 2-(azidomethyl)aziridine-2-carboxylates 18a-d were prepared in good to 
excellent yield by reaction with sodium azide in DMSO at 60 °C (Table 4, entries 
6-9). 2-(Azidomethyl)aziridines are also scarcely reported in the literature 
(Jamookeeah et al. 2008; Han et al. 2008; D’hooghe et al. 2005a). Methyl 
(2R,3R)-1-benzyl-3-(azidomethyl)-2-aziridinecarboxylate has been used in routes 
towards the synthesis of aziridinomitosenes as antitumor antibiotics (Shaw et al. 
1985). Upon reaction of ethyl 2-(bromomethyl)aziridine-2-carboxylates 14a-b 
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with phenol and K2CO3 in a mixture of acetone and DMF (1/1) under reflux, no 
satisfactory results were obtained even after prolonged reaction time (Table 4, 
entries 10-11). However, treating ethyl 2-(bromomethyl)aziridine-2-carboxylates 
14a-b with phenol and K2CO3 in DMSO at 60 °C for 5 to 16 hours afforded ethyl 
1-tert-butyl-2-(phenoxymethyl)aziridine-2-carboxylate 19a and ethyl 1-tert-
pentyl-2-(phenoxymethyl)aziridine-2-carboxylate 19b in 60 – 67% yield (Table 4, 
entries 12-14). Noteworthy, besides the aziridines 19 as major compounds, the 
rearranged compounds, i.e. ethyl 1-tert-butyl-3-phenoxyazetidine-3-carboxylate 
20a and ethyl 1-tert-pentyl-3-phenoxyazetidine-3-carboxylate 20b, were isolated 
in small amounts (4-5%) from this reaction. 2-(Aryloxymethyl)aziridines have 
recently been used for the synthesis of biologically relevant 2-amino-1-aryloxy-3-
methoxypropanes (D’hooghe et al. 2006b), and for the synthesis of 1H-tetrazole-
1-alkanenitriles as potent orally bioavailable growth hormone secretagogues 
(Hernández et al. 2008). 
In analogy with the reactions of aziridines 14, treatment of the 3-bromoazetidines 
15 with potassium cyanide, potassium thiocyanate, sodium azide and potassium 
phenoxide in DMSO at 60 °C for 3 to 4 hours afforded the corresponding 3-
cyano-, 3-thiocyano-, 3-azido- and 3-phenoxyazetidine-3-carboxylic esters 20-23 
in 36-98% yield (Table 5). 3-Substituted azetidines are frequently used in 
structure-activity relationship (SAR) studies for the preparation of libraries of 
bioactive compounds, e.g. bronchodilating and anti-inflammatory drugs (Provins 
et al. 2007), antibacterial agents (Murphy
 
et al. 2007), and antidepressant agents 
(Melloni et al. 1979). 
 
In order to extend the potential applicability of the synthesized constrained amino 
acid derivatives as building blocks for the synthesis of foldamers, the deprotection 
of several amino acid derivatives was studied as well. Using simple 
hydrogenolysis, ethyl 1-tert-pentyl-2-(azidomethyl)aziridine-2-carboxylate 18b 
and 1-tert-butyl-3-azidoazetidine-3-carboxylate 23a were converted into the 
corresponding ethyl 2-(aminomethyl)aziridine-2-carboxylate 24b and 3-
aminoazetidine-3-carboxylate 26a (Scheme 1 and 2). 
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Table 5 Reactions of alkyl 3-bromoazetidines 15 with different nucleophiles 
(see table)
N
COOR1Nu
R2
20 (Nu = OPh)
21 (Nu = CN)
22 (Nu = SCN)
23 (Nu = N3)
N
COOR1Br
R2
15a (R1 = Et, R2 = t-Bu)
15b (R1 = Et, R2 = t-Pentyl)
15c (R1 = Me, R2 = t-Bu)
 
Entry Substrate Reaction conditions Result (%) 
1 15a 2 equiv KCN, DMSO, 60 ºC, 4 h 21a (79) 
2 15a 1.5 equiv KSCN, DMSO, 60 ºC, 3 h 22a (59) 
3 15b 1.5 equiv KSCN, DMSO, 60 ºC, 3 h 22b (83) 
4 15a 2 equiv NaN3, DMSO, 60 ºC, 3 h 23a (86) 
5 15b 2 equiv NaN3, DMSO, 60 ºC, 3 h 23b (98) 
6 15c 2 equiv NaN3, DMSO, 60 ºC, 3 h 23c (79) 
7 15a 3 equiv PhOH, 6 equiv K2CO3, DMSO, 60 ºC, 3 h 20a (36) 
8 15b 2.5 equiv PhOH, 5 equiv K2CO3, DMSO, 60 ºC, 4 h 20b (81) 
 
 
Noteworthy, the ring opening of 2-(aminomethyl)aziridine templates with thioacid 
peptides has recently been developed as a method for chemoselective 
peptidomimetic ligation (Assem et al. 2010). Furthermore, 2-
(azidomethyl)aziridines 18 could be directly transformed into the corresponding 
N-Boc-protected 2-(aminomethyl)aziridines 25 by hydrogenation in the presence 
of di-tert-butyl dicarbonate (Scheme 1). All efforts to saponify 2-
(azidomethyl)aziridine-2-carboxylic esters via basic hydrolysis (aq. Na2CO3 or aq. 
LiOH) failed, resulting in either no reaction or formation of complex reaction 
mixtures. However, simple hydrolysis of ethyl 3-azidoazetidine-3-carboxylates 
23a,b to the corresponding 3-azidoazetidine-3-carboxylic acids 27 was achieved 
upon reaction with 2N aqueous NaOH solution in methanol at room temperature 
for 3 h (Scheme 2). Further hydrogenolysis of 3-azidoazetidine-3-carboxylic acids 
27 afforded 3-aminoazetidine-3-carboxylic acids 28. Besides their potential use as 
foldameric building blocks, the elaborated 3-aminoazetidine-3-carboxylates 26-28 
can be important for the synthesis of series of active compounds used in SAR, as 
exemplified for EGF receptor tyrosine kinase inhibitors (Hennequin et al. 2006), 
CB1 receptor antagonists (Brandt et al. 2009), and modulators of the NMDA 
receptor complex (Kozikowski and Fauq 1991). 
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1824b (68%)
Pd/C, H2 (4 bar)
EtOH, 3 h, r.t.
N
t-Pentyl
COOEt
NH2
N
R2
COOR1
N3
Pd/C, H2 (5-10 bar)
5 equiv Boc2O
CH3CN, 3-5 h, r.t.
25b (R1 = Et, R2 = t-Pentyl, 62%)
25c (R1 = Me, R2 = t-Bu, 76%)
N
R2
COOR1
NHBoc
 
Scheme 1 
 
3) Dowex
N
COOHN3
R1
N
COOHH2N
R11) Pd/C, H2 (3 bar)
    MeOH, r.t., 3 h
1) 2N NaOH (aq), MeOH, r.t., 3 h
2) 1N HCl (aq)
27a (R1 = t-Bu, 90%)
27b (R1 = t-Pentyl, 76%)
28a (R1 = t-Bu, 76%)
28b (R1 = t-Pentyl, 80%)
2) Dowex
N
COOEtN3
R2
23
Pd/C, H2 (4 bar)
EtOH, 3 h, r.t.
R2 = t-Bu
N
COOEtH2N
26a (78%)
t-Bu
 
Scheme 2 
 
In conclusion, a short synthesis of alkyl 2-(bromomethyl)aziridine-2-carboxylates 
and alkyl 3-bromoazetidine-3-carboxylates was developed involving amination, 
bromination, and base-induced cyclization of alkyl 2-(bromomethyl)acrylates. 
The aziridines are the kinetically favored cyclization products and could be 
transformed into 3-bromoazetidine-3-carboxylic acid derivatives via thermal 
isomerization. The new small ring azaheterocyclic α- and β-amino acid 
derivatives proved to be excellent building blocks for the synthesis of different 
substituted aziridines and azetidines through nucleophilic substitution of the 
bromide by different carbon, sulfur, oxygen and nitrogen nucleophiles in good to 
high yields. Elaboration of the amino and carboxyl group made new 
conformationally constrained functionalized α- and β-amino acids synthetically 
accessible for potential application in foldamer research. 
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